A review of the upcoming schedule of the Institute for Value-Based Medicine.
As students around the country head to class, it’s “back to school” season for the Institute for Value-Based Medicine® (IVBM), part of The American Journal of Managed Care®.
Although health systems and oncology practices host IVBM sessions year-round, the weeks of late August and early September have historically been popular times for these sessions, which offer participants an informal setting to get clinical or health care delivery updates and to network with colleagues, health system leaders, regional health partners.
This week starts a busy stretch of IVBM sessions in both oncology and population health, featuring both recurring sessions and new partners. Locally produced IVBM sessions feature content developed by local chairs, and each one reflects the flavor and priorities of the host institution. No fee is required, and dinner and drinks are provided; advance registration is requested.
Upcoming events include:
IVBM Oncology with Tennessee Oncology, August 22, 2024: Taking place at the Conrad Nashville, in Nashville, Tennessee from 5 to 9 PM,
“Innovating Health: Entrepreneurship in Specialty Care Delivery” will be cochaired by Katherine Baker, MD, MMHC, Tennessee Oncology; Samyukta Mullangi, MD, MBA, Tennessee Oncology and Thyme Care; and Leah Owens DNP, RN, BMTCN, OCN, Tennessee Oncology. Speakers will be from Tennessee Oncology, OneOncology, Vanderbilt University Medical Center, Thyme Care, UnitedHealth, Carrum Health, Martin Ventures, LRVHealth, Ascension St. Thomas, and Frist Cressey Ventures. For full speaker list and registration, visit here.
IVBM Population Health with the University of Colorado Anschutz Medical Campus, August 22, 2024: This event, taking place at the Benson Hotel in Aurora, Colorado, from 5 to 9 PM, is titled, “Payvider: Bridging the Gap Between Providers and Payers,” and will include sessions on bridging payer coverage gaps in neurological disease. The event will feature several faculty from the University of Colorado Anschutz Medical Campus, including R. Brett McQueen, PhD, who will discuss “Value Frameworks in Neurological Rare Disease,” and speakers from Colorado Medicaid, Rocky Mountain Neurology, and Lockton Inc. For full speaker list and registration, visit here.
IVBM Oncology with Florida Cancer Specialists & Research Institute (FCS), August 28, 2024: Breaking down the silos is the focus of this event,
“Transforming Trends: Navigating Advancements in Value-Based Oncology Care,” which features faculty from FCS and from Carrum Health, Augusta University, Carrum Health, and FCS research partner Sarah Cannon Cancer Network. Taking place from 5 to 9 PM at Le Méridien Tampa, The Courthouse, the evening offers a pair of network sessions and concludes with a session on creating an atmosphere for collaboration between payers and providers, led by Kiana Mehring, MBA. For a full speaker list and registration, visit here.
IVBM Population Health with Providence, August 29, 2024: The Hyatt Regency Seattle will be the setting for “Integrative Approaches in Neuroscience Population Health: Enhancing Pharmacy Operations and Clinical Services,” to be held from 5 to 9 PM. Cochairs Mike A. Skafi, RPh, MSQA, of Providence, and Sophia Humphreys, PharmD, MHA, BCBBS, of Sutter Health, will lead this discussion covering disease areas including multiple sclerosis and Alzheimer disease and topics to include medication access, the role of biosimilars, pain management, and the “Use of Artificial Intelligence in Formulary Analysis,” by Steve Pickette, PharmD.
IVBM Oncology with Minnesota Oncology, September 10, 2024: Another annual event,
this year’s theme will be “The Business of Oncology: Improving Outcomes, Providing Value, Reducing Cost,” to be held 5 to 8:30 PM at the Cambria Hotel Minneapolis Airport. Chair Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, will welcome faculty from Mayo Clinic, including Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, and McKesson to discuss making the financial side of cancer care work within new CMS mandates. For full speaker list and to register, visit here.
IVBM Oncology with City of Hope, September 19, 2024: “Prioritizing the Patient in Value-Based Oncology Care” will bring the City of Hope community to the Hyatt Regency Orange County in Garden Grove for this event, which takes place 5 to 9 PM. Chair Joseph Alvarnas, MD, will lead a program to include Richard Lee, MD, named last year as the Cherng Family Director's Chair of the Center for Integrative Oncology, as well as Steven Rosen, MD, who will discuss how leading comprehensive cancer centers must balance delivering high-value care within the limits of managed care. Other topics include patient access and unmet needs in supportive care. For a full speaker list and to register, visit here.
With Hidradenitis Suppurativa, Maternal and Offspring Outcomes May Suffer
October 31st 2024Novel evidence has emerged from a 16-year study that hidradenitis suppurativa can elevate risks of not only pregnancy and postpartum complications, but of morbidity—particularly metabolic- and immunology-related morbidity—for mother and child in the long term.
Read More
Building Trust, Breaking Barriers: Health Care Leaders Tackle Primary Care Challenges
August 8th 2024On this episode of Managed Care Cast, we're talking with the chief medical officers of CVS Health and Aetna, as well as CVS Health's chief health equity officer, about primary and preventive care engagement, the impact of telehealth, and the role of trust in patient-provider relationships.
Listen
Low Pulmonary Rehabilitation, Palliative Care Referrals for Patients With IPF Persist
October 30th 2024Despite proven benefits, referrals to pulmonary rehabilitation and palliative care for patients with idiopathic pulmonary fibrosis (IPF) in England remain significantly lower than for other respiratory conditions.
Read More
New AI Tool Identifies Undiagnosed PNH in Health Records
October 30th 2024The machine learning model shows promise in detecting paroxysmal nocturnal hemoglobinuria (PNH) by assessing electronic health records (EHR) data, potentially transforming the diagnostic landscape for rare diseases.
Read More